Investor Relations (IR) Questions: Arqule Inc ARQL

1) When is the last time ARQL raised cash through an offering (diluted)? In April 2012, ArQule completed an offering of 8.2 million shares, raising approximately $56 million in net proceeds.

2) How much cash (not cash equivalents) does ARQL have? ArQule has guided to ending 2012 with between $127 and $130 million in cash and marketable securities. At the end of the third quarter of 2012, the Company had a total of approximately $140 million in cash, equivalents and marketable securities, of which approximately $83 million is broken out into cash, equivalents and marketable securities – short term and approximately $57 million is broken out into Marketable securities – long term .

3) What and approximately when is the next known catalyst? The next potential catalysts include complete/final data read-outs and presentations from lung cancer and colorectal cancer trials expected to begin in mid-2013 and lasting through early 2014.

4) What is ARQL's quarterly cash burn? ArQule does not provide quarterly cash burn guidance. For 2012, the Company has guided to a net use of cash ranging between $35 and $38 million.

5) Does ARQL have an existing line of credit and if so how much can they draw against it? No